TD Cowen cuts Blueprint Medicines stock rating following Sanofi acquisition

Finance
3



[
TD Cowen cuts Blueprint Medicines stock rating following Sanofi acquisition
[og_img]
https://www.investing.com/news/analyst-ratings/td-cowen-cuts-blueprint-medicines-stock-rating-following-sanofi-acquisition-93CH-4077150


Investing.com

Montather Rassoul
Montather Rassoulhttps://thefifthskill.com/

Latest articles

spot_imgspot_img
Previous article
This millennial launched her fashion brand House of CB on eBay at 17 years old—now it’s making $200 million a year and worn by the Kardashians
Next article
emerging markets: Weaker dollar and emerging market flows support a bullish case for India: Matt Orton

Related articles

spot_imgspot_img